stella
beta
A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) — Stella
Recruiting
Back to Systemic Lupus Erthematosus (SLE) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Australia
Investigational site, Brisbane
View full record on ClinicalTrials.gov